Enanta Pharmaceuticals, Inc. (ENTA)
14.45
-0.19
(-1.30%)
USD |
NASDAQ |
Feb 26, 15:30
Enanta Pharmaceuticals Free Cash Flow : -18.46M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Agios Pharmaceuticals, Inc. | -377.29M |
| ACADIA Pharmaceuticals, Inc. | 98.97M |
| Alnylam Pharmaceuticals, Inc. | 465.38M |
| Savara, Inc. | -99.27M |
| BioMarin Pharmaceutical, Inc. | 717.02M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -11.70M |
| Cash from Investing (Quarterly) | -47.30M |
| Cash from Financing (Quarterly) | 64.14M |
| Free Cash Flow Per Share (Quarterly) | -0.4119 |
| Free Cash Flow to Equity (Quarterly) | -3.969M |
| Free Cash Flow to Firm (Quarterly) | -8.753M |
| Free Cash Flow Yield | -5.50% |